TS
CELL

Thomas Steyer’s PhenomeX Inc. Common Stock CELL Stock Holding History

Thomas Steyer’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-787,327
Closed -$14.3M – 339
2021
Q4 		$14.3M Buy
+787,327
New +$17M 0.07% 109

Other funds holding CELL

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
SUT
SC US (TTGP) Menlo Park, California $31.9B AUM 28.45% 1-Year Est. Return

Thomas Steyer's CELL Position: Q1 2022 in Review

Thomas Steyer sold out of PhenomeX Inc. Common Stock (CELL) in Q1 2022, closing a stake of 787,327 shares — an estimated $14.3M sold.

Thomas Steyer first reported a position in CELL in Q4 2021 and held it in 1 quarter. The position peaked at $14.3M in Q4 2021. 130 funds tracked by Wall St. Rank hold CELL as of Q1 2022.

  • Thomas Steyer reported no remaining PhenomeX Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Thomas Steyer sold 787,327 PhenomeX Inc. Common Stock shares in Q1 2022, an estimated $14.3M.
  • Thomas Steyer first reported a position in PhenomeX Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • Thomas Steyer's PhenomeX Inc. Common Stock position peaked at $14.3M in Q4 2021.
  • 130 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q1 2022.

Based on Farallon Capital Management's 13F filing for Q1 2022, filed 16 May 2022.